Hereditary Hemorrhagic Telangiectasia Center of Excellence
The Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence, part of Stanford Health Care, specializes in the diagnosis and treatment of HHT, a genetic disorder characterized by abnormalities in blood vessels. With a comprehensive care approach, their multidisciplinary team offers individualized treatment plans and support for patients experiencing symptoms such as nosebleeds, gastrointestinal bleeding, and arteriovenous malformations.
Recognized for their expertise, the HHT Center collaborates with Stanford Medicine Children's Health to provide a unique approach to care, ensuring thorough assessments and diagnostic testing. Their commitment to advancing HHT treatment includes participation in clinical trials and a focus on patient education and support resources.
Generated from the website